Reduced kynurenine pathway metabolism and cytokine expression in the prefrontal cortex of depressed individuals
Author(s) -
Sarah M. Clark,
Ana Pocivavsek,
James D. Nicholson,
Francesca M. Notarangelo,
Patricia Langenberg,
Robert P. McMahon,
Joel E. Kleinman,
Thomas M. Hyde,
John W. Stiller,
Teodor T. Postolache,
Robert Schwarcz,
Leonardo H. Tonelli
Publication year - 2016
Publication title -
journal of psychiatry and neuroscience
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.767
H-Index - 99
eISSN - 1488-2434
pISSN - 1180-4882
DOI - 10.1503/jpn.150226
Subject(s) - quinolinic acid , kynurenine pathway , kynurenic acid , kynurenine , indoleamine 2,3 dioxygenase , prefrontal cortex , endocrinology , medicine , biology , tryptophan , biochemistry , glutamate receptor , neuroscience , receptor , amino acid , cognition
Neuroinflammatory processes are increasingly believed to participate in the pathophysiology of a number of major psychiatric diseases, including depression. Immune activation stimulates the conversion of the amino acid tryptophan to kynurenine, leading to the formation of neuroactive metabolites, such as quinolinic acid and kynurenic acid. These compounds affect glutamatergic neurotransmission, which plays a prominent role in depressive pathology. Increased tryptophan degradation along the kynurenine pathway (KP) has been proposed to contribute to disease etiology.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom